Latest Insider Transactions at Alkermes Plc. (ALKS)
This section provides a real-time view of insider transactions for Alkermes Plc. (ALKS). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Alkermes plc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Alkermes plc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 21
2022
|
Richard F Pops Director and CEO, Alkermes plc |
BUY
Exercise of conversion of derivative security
|
Direct |
32,400
+3.55%
|
-
|
|
Feb 21
2022
|
Craig C. Hopkinson EVP R&D, Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,022
-8.6%
|
$50,550
$25.08 P/Share
|
|
Feb 21
2022
|
Craig C. Hopkinson EVP R&D, Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,875
+22.63%
|
-
|
|
Feb 20
2022
|
Iain Michael Brown SVP, Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,348
-2.55%
|
$33,700
$25.08 P/Share
|
|
Feb 20
2022
|
Iain Michael Brown SVP, Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,589
+7.98%
|
-
|
|
Feb 20
2022
|
David Joseph Gaffin EVP, CLO, Alkermes, Inc. |
SELL
Payment of exercise price or tax liability
|
Direct |
2,061
-2.29%
|
$51,525
$25.08 P/Share
|
|
Feb 20
2022
|
David Joseph Gaffin EVP, CLO, Alkermes, Inc. |
BUY
Exercise of conversion of derivative security
|
Direct |
7,036
+7.26%
|
-
|
|
Feb 20
2022
|
Blair Curtis Jackson EVP, Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,335
-1.69%
|
$33,375
$25.08 P/Share
|
|
Feb 20
2022
|
Blair Curtis Jackson EVP, Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,589
+5.48%
|
-
|
|
Feb 20
2022
|
Michael J Landine SVP, Corp Dev., Alkermes, Inc. |
SELL
Payment of exercise price or tax liability
|
Direct |
2,368
-1.04%
|
$59,200
$25.08 P/Share
|
|
Feb 20
2022
|
Michael J Landine SVP, Corp Dev., Alkermes, Inc. |
BUY
Exercise of conversion of derivative security
|
Direct |
5,354
+2.29%
|
-
|
|
Feb 20
2022
|
Christian Todd Nichols SVP, Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,252
-5.6%
|
$31,300
$25.08 P/Share
|
|
Feb 20
2022
|
Christian Todd Nichols SVP, Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,824
+14.6%
|
-
|
|
Feb 20
2022
|
Craig C. Hopkinson EVP R&D, Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,966
-15.14%
|
$74,150
$25.08 P/Share
|
|
Feb 20
2022
|
Craig C. Hopkinson EVP R&D, Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,096
+34.01%
|
-
|
|
Feb 18
2022
|
Craig C. Hopkinson EVP R&D, Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
2,306
-19.54%
|
$57,650
$25.17 P/Share
|
|
Feb 16
2022
|
Richard F Pops Director and CEO, Alkermes plc |
SELL
Payment of exercise price or tax liability
|
Direct |
8,038
-0.94%
|
$208,988
$26.79 P/Share
|
|
Feb 16
2022
|
Richard F Pops Director and CEO, Alkermes plc |
BUY
Exercise of conversion of derivative security
|
Direct |
18,125
+2.07%
|
-
|
|
Feb 16
2022
|
David Joseph Gaffin EVP, CLO, Alkermes, Inc. |
SELL
Payment of exercise price or tax liability
|
Direct |
1,098
-1.31%
|
$28,548
$26.79 P/Share
|
|
Feb 16
2022
|
David Joseph Gaffin EVP, CLO, Alkermes, Inc. |
BUY
Exercise of conversion of derivative security
|
Direct |
3,375
+3.87%
|
-
|
|
Feb 16
2022
|
Craig C. Hopkinson EVP R&D, Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,069
-8.31%
|
$27,794
$26.79 P/Share
|
|
Feb 16
2022
|
Craig C. Hopkinson EVP R&D, Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,375
+20.77%
|
-
|
|
Feb 16
2022
|
Michael J Landine SVP, Corp Dev., Alkermes, Inc. |
SELL
Payment of exercise price or tax liability
|
Direct |
1,620
-0.72%
|
$42,120
$26.79 P/Share
|
|
Feb 16
2022
|
Michael J Landine SVP, Corp Dev., Alkermes, Inc. |
BUY
Exercise of conversion of derivative security
|
Direct |
3,375
+1.48%
|
-
|
|
Feb 16
2022
|
Iain Michael Brown SVP, Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
825
-1.68%
|
$21,450
$26.79 P/Share
|
|
Feb 16
2022
|
Iain Michael Brown SVP, Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,375
+4.61%
|
-
|
|
Feb 16
2022
|
Blair Curtis Jackson EVP, Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
825
-1.09%
|
$21,450
$26.79 P/Share
|
|
Feb 16
2022
|
Blair Curtis Jackson EVP, Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,375
+3.05%
|
-
|
|
Feb 10
2022
|
Brian P Mckeon Director |
SELL
Payment of exercise price or tax liability
|
Direct |
2,735
-36.35%
|
$62,905
$23.55 P/Share
|
|
Feb 10
2022
|
Brian P Mckeon Director |
BUY
Exercise of conversion of derivative security
|
Direct |
6,669
+46.79%
|
-
|
|
Feb 10
2022
|
David Angelo Daglio Jr. Director |
SELL
Payment of exercise price or tax liability
|
Direct |
2,735
-29.91%
|
$62,905
$23.55 P/Share
|
|
Feb 10
2022
|
David Angelo Daglio Jr. Director |
BUY
Exercise of conversion of derivative security
|
Direct |
6,669
+40.72%
|
-
|
|
Dec 02
2021
|
Shane Cooke Director |
SELL
Payment of exercise price or tax liability
|
Direct |
2,901
-3.11%
|
$63,822
$22.11 P/Share
|
|
Dec 02
2021
|
Shane Cooke Director |
BUY
Exercise of conversion of derivative security
|
Direct |
5,578
+5.64%
|
-
|
|
Dec 02
2021
|
David W Anstice Director |
SELL
Payment of exercise price or tax liability
|
Direct |
1,339
-1.7%
|
$29,458
$22.11 P/Share
|
|
Dec 02
2021
|
David W Anstice Director |
BUY
Exercise of conversion of derivative security
|
Direct |
5,578
+6.62%
|
-
|
|
Dec 02
2021
|
Wendy L Dixon Director |
SELL
Payment of exercise price or tax liability
|
Direct |
1,339
-2.86%
|
$29,458
$22.11 P/Share
|
|
Dec 02
2021
|
Wendy L Dixon Director |
BUY
Exercise of conversion of derivative security
|
Direct |
5,578
+10.63%
|
-
|
|
Dec 02
2021
|
Richard Gaynor Director |
SELL
Payment of exercise price or tax liability
|
Direct |
1,339
-13.03%
|
$29,458
$22.11 P/Share
|
|
Dec 02
2021
|
Richard Gaynor Director |
BUY
Exercise of conversion of derivative security
|
Direct |
5,578
+35.18%
|
-
|
|
Dec 02
2021
|
Nancy Lynn Md Snyderman Director |
SELL
Payment of exercise price or tax liability
|
Direct |
1,339
-13.03%
|
$29,458
$22.11 P/Share
|
|
Dec 02
2021
|
Nancy Lynn Md Snyderman Director |
BUY
Exercise of conversion of derivative security
|
Direct |
5,578
+35.18%
|
-
|
|
Dec 02
2021
|
Frank Anders Wilson Director |
SELL
Payment of exercise price or tax liability
|
Direct |
1,339
-13.03%
|
$29,458
$22.11 P/Share
|
|
Dec 02
2021
|
Frank Anders Wilson Director |
BUY
Exercise of conversion of derivative security
|
Direct |
5,578
+35.18%
|
-
|
|
Dec 02
2021
|
Nancy Wysenski Director |
SELL
Payment of exercise price or tax liability
|
Direct |
1,339
-13.03%
|
$29,458
$22.11 P/Share
|
|
Dec 02
2021
|
Nancy Wysenski Director |
BUY
Exercise of conversion of derivative security
|
Direct |
5,578
+35.18%
|
-
|
|
Sep 14
2021
|
Iain Michael Brown SVP, Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,057
-6.13%
|
$91,710
$30.6 P/Share
|
|
Sep 14
2021
|
Iain Michael Brown SVP, Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
6,884
+12.13%
|
-
|
|
Sep 14
2021
|
David Joseph Gaffin EVP, CLO, Alkermes, Inc. |
SELL
Payment of exercise price or tax liability
|
Direct |
4,634
-5.44%
|
$139,020
$30.6 P/Share
|
|
Sep 14
2021
|
David Joseph Gaffin EVP, CLO, Alkermes, Inc. |
BUY
Grant, award, or other acquisition
|
Direct |
10,555
+11.03%
|
-
|